Trial Profile
Valsartan Amlodipine Randomized Trial.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Jan 2012
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Valsartan (Primary)
- Indications Cardiovascular disorders; Essential hypertension
- Focus Therapeutic Use
- Acronyms VART
- 12 Jan 2012 Planned End Date changed to 1 Dec 2008 as reported by University Hospital Medical Information Network - Japan.
- 29 Aug 2009 Results presented at ESC Congress 2009: Annual Congress of the European Society of Cardiology.
- 06 Jul 2007 Status change